24.76
-0.74(-2.90%)
Currency In USD
| Previous Close | 25.5 |
| Open | 25.76 |
| Day High | 25.57 |
| Day Low | 24.76 |
| 52-Week High | 35 |
| 52-Week Low | 18.35 |
| Volume | 13,432 |
| Average Volume | 33,141 |
| Market Cap | 296.3M |
| PE | -33.92 |
| EPS | -0.73 |
| Moving Average 50 Days | 22.9 |
| Moving Average 200 Days | 26.22 |
| Change | -0.74 |
If you invested $1000 in XOMA Corporation (XOMA) 10 years ago, it would be worth $353.71 as of June 01, 2025 at a share price of $24.76. Whereas If you bought $1000 worth of XOMA Corporation (XOMA) shares 5 years ago, it would be worth $1,233.07 as of June 01, 2025 at a share price of $24.76.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
GlobeNewswire Inc.
May 27, 2025 12:01 PM GMT
EMERYVILLE, Calif. and LUND, Sweden, May 27, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, and BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the d
XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference
GlobeNewswire Inc.
May 07, 2025 11:30 AM GMT
EMERYVILLE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen Hughes, and Chief Investment Officer, Brad Sitko, will be featured speak
XOMA Royalty Completes Sale of Kinnate Pipeline Assets
GlobeNewswire Inc.
Apr 14, 2025 11:30 AM GMT
XOMA Royalty sold the remaining Kinnate pipeline assets for a total of up to $270 million in upfront and milestone payments, plus royalties on commercial sales at rates ranging from low single digits to mid-teens Holders of Kinnate Contingent Value R